This information is intended for US healthcare professionals.

Brought to you by Gilead Oncology logo in white text.

HEAR EXPERT PERSPECTIVES REVIEW THE CLUES

Keep up with the investigation with these quick overview videos

A video investigating higher-risk MDS.

Investigating the Ongoing Case Against HR-MDS

A video digging into discoveries for MDS.

Insights for Discoveries

A video taking a closer look at immunotherapy.

A Closer Look at Immunotherapy

A video discussing the urgent need for more effective treatments.

Urgent Need for More Effective Treatments

A video investigating into innovation for MDS.

An Investigation Into Innovation

A video looking at the immune system and MDS.

Clues From the Immune System

A video about macrophages and MDS.

Focusing on Macrophages

A video about understanding CD47 overexpression.

Understanding CD47 Overexpression

A video explaining how HR-MDS uses CD47 to hide from the immune system.

How Does HR-MDS Use CD47 to Hide From the Immune System?

Be sure to get updates from Gilead as the case evolves

Register
for Updates

HR-MDS, higher-risk myelodysplastic syndrome; MDS, myelodysplastic syndrome.

GILEAD and the GILEAD Logo are trademarks of Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, CA 94404 © 2022 Gilead Sciences, Inc. All rights reserved. US-UNBP-1291 11/22